HDAC2 and chronic obstructive pulmonary disease: Previous reports have demonstrated that HDAC2 expression and activity are significantly reduced in human COPD (Qu, Yang, Ma, He, & Xiao, 2013), as well as in cigarette smoke (CS)‐exposed mouse lungs (Adenuga, Yao, March, Seagrave, & Rahman, 2009).